i
Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline
-
11/15/2019
-
Source: IDSA Practice Guidelines
Details:
-
Personal Author:
-
Corporate Authors:
-
Description:The American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America jointly sponsored this new practice guideline on the treatment of drug-resistant tuberculosis (DR-TB). The document includes recommendations on treatment of multidrug-resistant TB (MDR-TB), as well as isoniazid-resistant but rifampin-susceptible TB.
-
Subjects:
-
Source:
-
Series:
-
Document Type:
-
Genre:
-
Place as Subject:
-
Pages in Document:p. 93-142
-
Volume:200
-
Issue:10
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: